Supplement Scholar
Metabolic / GLP-1

Liraglutide

Research compound. This is not a dietary supplement. Unless it is identified as an approved prescription drug, it is not approved by the FDA for human use. This page summarizes published research for education only; we do not sell it or link to sellers.

Liraglutide. Daily GLP-1 receptor agonist with a shorter half-life than semaglutide.

How it works. Activates GLP-1 receptors for glucose-dependent insulin release, glucagon suppression, slowed gastric emptying, and central appetite reduction.

What the research supports. 3 graded claims. Strongest: Established safety record (preclinical).

Hormonal impact. Effects on Insulin, Glucagon, Ghrelin.

Side effects and interactions. 1 medication interaction listed. Serious: Pancreatitis (rare).

Stacking. Pairs well with Lifestyle program. Avoid combining with Personal or family history of MTC or MEN2.

Common forms. Available as Daily subcutaneous injection.

Community. Experiences from people who have tried Liraglutide. Anecdotes are not medical advice.

Liraglutide. Daily GLP-1 receptor agonist with a shorter half-life than semaglutide.

No single structure

What it is

Liraglutide is a once-daily GLP-1 analog with a fatty-acid chain that supports albumin binding and a roughly 13-hour half-life.

Also called

VictozaSaxenda

How it works

Activates GLP-1 receptors for glucose-dependent insulin release, glucagon suppression, slowed gastric emptying, and central appetite reduction.

Pathways

  • GLP-1 receptor agonism

Effects

  • ↓Appetite decreases
  • ↑Glucose-dependent insulin secretion increases
  • ↓Body weight (modest) decreases

What the research supports

Established safety recordpreclinical
Approved for both diabetes and weight losspreclinical
Flexible daily dosingpreclinical

Strong: consistent results across large trials or meta-analyses. Moderate: several trials, mostly positive. Limited: small or mixed studies. Preclinical: animal or cell research only.

Hormonal impact

↑Insulinincreases
↓Glucagondecreases
↓Ghrelindecreases

Side effects & interactions

Common side effects

  • Nausea
  • Diarrhea
  • Constipation

Serious

  • Pancreatitis (rare)
  • Thyroid C-cell tumor risk (rodent data)

Medication interactions

Sulfonylureas or insulinmoderate

Hypoglycemia risk.

Check any supplement–medication combination with your pharmacist before starting.

Combines with

Pairs well

  • Lifestyle programImproves adherence and outcome.

Avoid combining

  • Personal or family history of MTC or MEN2Boxed contraindication.

Common forms

  • Daily subcutaneous injection

Discussion

Loading discussion…